source
- GLP-1 drugs shift from obesity treatment to lifestyle products, prompting setbacks for Merck and DaiichiThe column notes that GLP-1 medicines, originally marketed to treat obesity as a medical condition, are now being promoted more as general lifestyle enhancers for appearance and wellbeing. Novo No…
- AI tools that aid vaccine design could also accelerate creation of bioweapons, warns former White House Covid adviserAshish K. Jha, a former White House Covid‑19 response coordinator and senior fellow at Harvard Kennedy School, cautions that artificial intelligence is lowering the barriers that kept biological we…